Prescription Medicines
Azela Tab.
- Product Category
- Asthma and allergic disease treatment
- Active Ingredients
- Azelastine hydrochloride
- Appearance
- Light beige round film-coated tablets
- Reimbursement Code
- 648101390
01 / 02
1. Composition and Strength
1 tablet
- Active ingredient: Azelastine hydrochloride (BP)----1mg
- Additives (animal-derived ingredients): Lactose hydrate (cow, milk)
- Other additives: microcrystalline cellulose, magnesium stearate, colloidal silicon oxide, talc, polyethylene glycol 6000, hypromellose 2910, iron sulfate
2. Effectiveness
Bronchial asthma, allergic rhinitis, urticaria, eczema, dermatitis, atopic dermatitis, pruritus, itching
3. Dosage and dosage
Azelastine hydrochloride is administered orally at 1 mg once a time, or in case of bronchial asthma, at 2 mg once a day, twice a day after breakfast and before bedtime.
Increase or decrease appropriately depending on age and symptoms.
4. Precautions for use
1. Do not administer to the following patients:
1) Infants under 6 years of age
2) Since this drug contains lactose, this drug should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactose deficiency, or glucose-galactose malabsorption.
2. Adverse reactions
1) Mental nervous system: Drowsiness, sometimes weariness, paralysis of the hands and feet, and rarely stumbling may occur.
2) Digestive system: Dry mouth, nausea, vomiting, coughing in the mouth, rarely, loss of appetite, abdominal pain, constipation, diarrhea, and stomach discomfort may occur.
3) Circulatory system: In rare cases, flushing of the face or shortness of breath may occur.
4) Respiratory system: Dryness may occur.
5) Soy sauce: Sometimes it can increase the activity of transaminase. Rarely, elevations of AST, ALT, and Al-P may occur.
6) Hypersensitivity: Sometimes rashes may occur, so if these symptoms appear, stop taking the drug.
7) Urinary system: Difficulty urinating, hematuria, and rarely, frequent urination may occur.
8) Blood system: In rare cases, an increase in white blood cells may occur.
9) Others: Edema and menstrual abnormalities may occur.
3. General precautions
1) Because it may cause drowsiness, patients taking this drug should be careful not to operate dangerous machinery such as driving a car.
2) If a patient receiving long-term steroid therapy wishes to reduce the steroid dose by administering this drug, do so slowly and under sufficient management.
3) When used for bronchial asthma, it is necessary to fully explain to the patient that this drug is not a drug that quickly relieves attacks that are already occurring.
4) When administering this drug to seasonal patients, it is advisable to start administration before the peak season and continue until the end of the peak season.
4. Interaction
Sedation may be enhanced by alcohol intake, and caution should be exercised when coadministered with cimetidine.
5. Administration to pregnant and lactating women
1) Since malformations have been reported in animal experiments due to large doses (more than 370 times the clinical dose), it should be administered to pregnant women or women who may be pregnant only when the therapeutic benefits are judged to outweigh the risks.
2) In animal experiments (rats), it has been reported that the drug passes into breast milk, so it is not recommended to be administered to women who are lactating. However, if administration is unavoidable, breastfeeding should be discontinued.
6. Administration to children
Safety for premature babies, newborns, infants, and young children has not been established. (There is little experience with use.)
7. Administration to elderly people
In general, menstrual function is reduced, so be careful about reducing weight.
8. Application precautions
A bitter taste, which is the taste of the drug itself, may appear.
9. Storage and handling precautions
1) Keep out of reach of children.
2) Avoid direct sunlight and store tightly in a cool place with as little moisture as possible.
3) To prevent misuse and preserve quality, do not replace the product in another container.
5. How to save
Store in a light-proof, airtight container at room temperature (1~30℃)
6. Packaging unit
30 tablets/bottle, 100 tablets/bottle
7. Period of use
36 months from date of manufacture
1 tablet
- Active ingredient: Azelastine hydrochloride (BP)----1mg
- Additives (animal-derived ingredients): Lactose hydrate (cow, milk)
- Other additives: microcrystalline cellulose, magnesium stearate, colloidal silicon oxide, talc, polyethylene glycol 6000, hypromellose 2910, iron sulfate
2. Effectiveness
Bronchial asthma, allergic rhinitis, urticaria, eczema, dermatitis, atopic dermatitis, pruritus, itching
3. Dosage and dosage
Azelastine hydrochloride is administered orally at 1 mg once a time, or in case of bronchial asthma, at 2 mg once a day, twice a day after breakfast and before bedtime.
Increase or decrease appropriately depending on age and symptoms.
4. Precautions for use
1. Do not administer to the following patients:
1) Infants under 6 years of age
2) Since this drug contains lactose, this drug should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactose deficiency, or glucose-galactose malabsorption.
2. Adverse reactions
1) Mental nervous system: Drowsiness, sometimes weariness, paralysis of the hands and feet, and rarely stumbling may occur.
2) Digestive system: Dry mouth, nausea, vomiting, coughing in the mouth, rarely, loss of appetite, abdominal pain, constipation, diarrhea, and stomach discomfort may occur.
3) Circulatory system: In rare cases, flushing of the face or shortness of breath may occur.
4) Respiratory system: Dryness may occur.
5) Soy sauce: Sometimes it can increase the activity of transaminase. Rarely, elevations of AST, ALT, and Al-P may occur.
6) Hypersensitivity: Sometimes rashes may occur, so if these symptoms appear, stop taking the drug.
7) Urinary system: Difficulty urinating, hematuria, and rarely, frequent urination may occur.
8) Blood system: In rare cases, an increase in white blood cells may occur.
9) Others: Edema and menstrual abnormalities may occur.
3. General precautions
1) Because it may cause drowsiness, patients taking this drug should be careful not to operate dangerous machinery such as driving a car.
2) If a patient receiving long-term steroid therapy wishes to reduce the steroid dose by administering this drug, do so slowly and under sufficient management.
3) When used for bronchial asthma, it is necessary to fully explain to the patient that this drug is not a drug that quickly relieves attacks that are already occurring.
4) When administering this drug to seasonal patients, it is advisable to start administration before the peak season and continue until the end of the peak season.
4. Interaction
Sedation may be enhanced by alcohol intake, and caution should be exercised when coadministered with cimetidine.
5. Administration to pregnant and lactating women
1) Since malformations have been reported in animal experiments due to large doses (more than 370 times the clinical dose), it should be administered to pregnant women or women who may be pregnant only when the therapeutic benefits are judged to outweigh the risks.
2) In animal experiments (rats), it has been reported that the drug passes into breast milk, so it is not recommended to be administered to women who are lactating. However, if administration is unavoidable, breastfeeding should be discontinued.
6. Administration to children
Safety for premature babies, newborns, infants, and young children has not been established. (There is little experience with use.)
7. Administration to elderly people
In general, menstrual function is reduced, so be careful about reducing weight.
8. Application precautions
A bitter taste, which is the taste of the drug itself, may appear.
9. Storage and handling precautions
1) Keep out of reach of children.
2) Avoid direct sunlight and store tightly in a cool place with as little moisture as possible.
3) To prevent misuse and preserve quality, do not replace the product in another container.
5. How to save
Store in a light-proof, airtight container at room temperature (1~30℃)
6. Packaging unit
30 tablets/bottle, 100 tablets/bottle
7. Period of use
36 months from date of manufacture
Product Updates
Total 2items
| No. | Product Name | Details | Date of Change | Download |
|---|---|---|---|---|
| 2 | Azela Tab. | Azela Tablet (Precautions for use) | 2009.10.07 | HWP9. Change order for permission (Azela tablets) (2009.10.07).hwp |
| 1 | Azela Tab. | Azela Tablet (Precautions for use) | 2007.12.11 | HWP9. Change order for permission (Azela tablets) (2007.12.11).hwp |